anonymous
Guest
anonymous
Guest
Had to laugh at this from the investors call this past week courtesy of Jack Khattar. Next time you're with your RD in a call, just walk out if the discussion of migraine comes up.
"Currently, in the marketplace -- and this adds to my answer before on that specific issue. We are very strict as far as to how we promote our product currently in epilepsy. And any discussion that -- if a physician raises a discussion about migraine, we just stop that discussion or walk out of that office."
http://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-184738304.html
"Currently, in the marketplace -- and this adds to my answer before on that specific issue. We are very strict as far as to how we promote our product currently in epilepsy. And any discussion that -- if a physician raises a discussion about migraine, we just stop that discussion or walk out of that office."
http://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-184738304.html